Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
|Articles|July 24, 2015
Dellann Elliott Mydland on Testing Brain Tumor Tissue
Author(s)Dellann Elliott Mydland
Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.
Advertisement
Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.
Advertisement
Related to this article
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma
2
How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care
3
Nurse-Led Support Reduces Death Anxiety in Breast Cancer Care
4
Delirium and Capacity in Cancer: Dr. Yesne Alici on Bioethics and Clinical Care
5